Microbial Products Market size is expected to grow at a CAGR of 10.2% during the forecast period and the market size is expected to reach nearly USD 492.06 Bn by 2030.Microbial Products Market Definition
Microbial products are extensively utilized in fermentation processes for the commercial production of microbial products like antibiotics, nutrients such as amino acids, vitamins, and organic acids, chemotherapeutic agents, vaccines. The main categories of microbial products are bacteria, viruses, fungi, molds and yeasts. The report study has analyzed revenue impact of covid-19 pandemic on the sales revenue of market leaders, market followers and disrupters in the report and same is reflected in our analysis.To know about the Research Methodology :- Request Free Sample Report
Microbial Products Market Dynamic
The report analyzes factors affecting microbial products market from both demand and supply side and further estimates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The agriculture industry is mounting with increasing the demand for microbial products. As per the MMR research, the agriculture industry is growing with the CAGR rate of ~7% in 2023 and it is generating the demand for all the products associated with agriculture. Also, the food and additives industry boosting the growth of the market owing to the increasing demand for dairy products. The production of enzymes for end-use industries such as paper, leather, and food preservation is impelling the growth of the market. Healthcare and agriculture products with the help of genetic recombinant technology are boosting to produce more environmental-friendly and cost-effective products. Rising demand for microbial products for clinical diagnostics products is a key factor fueling the global microbial products market.Microbial Products Market Key Developments
In July 2019, DMC has managed to raise Series, equity financing backed by the support of Sofinnova Partners. The former will be using its technology to bring down biological complexity and also accelerate the speed of development. This will lead to low cost and fermentation-based manufacturing platform with the capability of generating a wide range of microbial products.Microbial Products Market Segment analysis
In terms of source, bacterial segment is expected to dominate the market during the forecast year. Bacteria cultures is widely used in research institutes and industrial application, include methicillin-resistant/sensitive research materials, quality control organisms for commercial identification systems, a wide selection of extremophile strains from a variety of environmental sources, and genomic DNA from well-characterized microbial strains suitable for amplification by PCR technique. Furthermore various bacterial specie, anaerobic bacteria, bacterial genome sequencing strain, are some techniques and culture method which is adopted by various industries for their research and development purpose, is expected to fuel the market in future.Microbial Products Market Regional Analysis
Regionally, North America is projected to witness the fastest growth during the forecast period. Factors like outstanding reimbursement, advancement in technology for R&D, high expenditure on healthcare sector. Microbial products are highly getting utilized in U.S because of, recent developed technologies for microbiology is expected to fuel the market in North America region. Furthermore, Europe is considered as a second largest region as consumption of microbial product is growing. The objective of the report is to present a comprehensive analysis of the Global Microbial Products Market including all the stakeholders of the industry. The past and current status of the industry with forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all the aspects of the industry with a dedicated study of key players that includes market leaders, followers and new entrants. PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors of the market have been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give a clear futuristic view of the industry to the decision-makers. The report also helps in understanding Global Microbial Products Market dynamics, structure by analyzing the market segments and project the Global Microbial Products Market size. Clear representation of competitive analysis of key players by Application, price, financial position, Product portfolio, growth strategies, and regional presence in the Global Microbial Products Market make the report investor’s guide.Microbial Products Market Scope: Inquire before buying
Microbial Products Market Report Coverage Details Base Year: 2023 Forecast Period: 2024-2030 Historical Data: 2018 to 2023 Market Size in 2023: US $ 249.31 Bn. Forecast Period 2024 to 2030 CAGR: 10.2% Market Size in 2030: US $ 492.06 Bn. Segments Covered: by Source Bacterial Viral Fungi by Type Enzymes Polysaccharides Nutrients Chemotherapeutic Agents Antibiotics Vaccines by Application Pharmaceutical Diagnostic Biotechnology by End-User Pharmaceutical and Biotechnological Industries Hospitals and Clinics Diagnostic Labs Research and Academics Microbial Products Market, by Region
North America (United States, Canada and Mexico) Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe) Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC) Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A) South America (Brazil, Argentina Rest of South America)Microbial Products Market, Key Players are
1. Kyowa Hakko Bio Co. 2. GlaxoSmithKline plc, 3. NovaDigm Therapeutics 4. Sanofi S.A 5. Novartis AG 6. Merck & Co. Inc. 7. Valent BioSciences Corp. 8. Amgen Inc. 9. Pfizer Inc., Ltd 10.Biomérieux SA 11.Ajinomoto Co. Inc. 12.Certis Usa 13.Durect Corp. 14.Earthrise Nutritionals Llc 15.Energy Derived 16.Environmental Biotechnologies Inc. 17.Genomatica 18.Genzyme Corp 19.Taiwan Chlorella Manufacturing Co. 20.Leadiant 21.AB Mauri 22.Genencor 23.Amyris Inc. Frequently Asked Questions: 1. Which region has the largest share in Global Microbial Products Market? Ans: North America region holds the highest share in 2023. 2. What is the growth rate of Global Microbial Products Market? Ans: The Global Market is growing at a CAGR of 10.2% during forecasting period 2024-2030. 3. What is scope of the Global Microbial Products market report? Ans: Global Market report helps with the PESTEL, PORTER, COVID-19 Impact analysis, Recommendations for Investors & Leaders, and market estimation of the forecast period. 4. Who are the key players in Global Microbial Products market? Ans: The important key players in the Global Market are – Kyowa Hakko Bio Co., GlaxoSmithKline plc,, NovaDigm Therapeutics, Sanofi S.A, Novartis AG, Merck & Co. Inc., Valent BioSciences Corp., Amgen Inc., Pfizer Inc., Ltd, Biomérieux SA, Ajinomoto Co. Inc., Certis Usa, Durect Corp., Earthrise Nutritionals Llc, Energy Derived, Environmental Biotechnologies Inc., Genomatica, Genzyme Corp, Taiwan Chlorella Manufacturing Co., Leadiant, AB Mauri, Genencor, and Amyris Inc. 5. What is the study period of this market? Ans: The Global Market is studied from 2023 to 2030.
Microbial Products Market 1. Preface 1.1. Report Scope and Market Segmentation 1.2. Research Highlights 1.3. Research Objectives 2. Assumptions and Research Methodology 2.1. Report Assumptions 2.2. Abbreviations 2.3. Research Methodology 2.3.1. Secondary Research 2.3.1.1. Secondary data 2.3.1.2. Secondary Sources 2.3.2. Primary Research 2.3.2.1. Data from Primary Sources 2.3.2.2. Breakdown of Primary Sources 3. Executive Summary: Microbial Products Market Size, by Market Value (US$ Bn) 4. Market Overview 4.1. Introduction 4.2. Market Indicator 4.2.1. Drivers 4.2.2. Restraints 4.2.3. Opportunities 4.2.4. Challenges 4.3. Porter’s Analysis 4.4. Value Chain Analysis 4.5. Market Risk Analysis 4.6. SWOT Analysis 4.7. Industry Trends and Emerging Technologies 5. Supply Side and Demand Side Indicators 6. Microbial Products Market Analysis and Forecast 6.1. Microbial Products Market Size & Y-o-Y Growth Analysis 6.1.1. North America 6.1.2. Europe 6.1.3. Asia Pacific 6.1.4. Middle East & Africa 6.1.5. South America 7. Microbial Products Market Analysis and Forecast, By Type 7.1. Introduction and Definition 7.2. Key Findings 7.3. Microbial Products Market Value Share Analysis, By Type 7.4. Microbial Products Market Size (US$ Bn) Forecast, By Type 7.5. Microbial Products Market Analysis, By Type 7.6. Microbial Products Market Attractiveness Analysis, By Type 8. Microbial Products Market Analysis and Forecast, By Application 8.1. Introduction and Definition 8.2. Key Findings 8.3. Microbial Products Market Value Share Analysis, By Application 8.4. Microbial Products Market Size (US$ Bn) Forecast, By Application 8.5. Microbial Products Market Analysis, By Application 8.6. Microbial Products Market Attractiveness Analysis, By Application 9. Microbial Products Market Analysis and Forecast, By Source 9.1. Introduction and Definition 9.2. Key Findings 9.3. Microbial Products Market Value Share Analysis, By Source 9.4. Microbial Products Market Size (US$ Bn) Forecast, By Source 9.5. Microbial Products Market Analysis, By Source 9.6. Microbial Products Market Attractiveness Analysis, By Source 10. Microbial Products Market Analysis and Forecast, By End-User 10.1. Introduction and Definition 10.2. Key Findings 10.3. Microbial Products Market Value Share Analysis, By End-User 10.4. Microbial Products Market Size (US$ Bn) Forecast, By End-User 10.5. Microbial Products Market Analysis, By End-User 10.6. Microbial Products Market Attractiveness Analysis, By End-User 11. Microbial Products Market Analysis, by Region 11.1. Microbial Products Market Value Share Analysis, by Region 11.2. Microbial Products Market Size (US$ Bn) Forecast, by Region 11.3. Microbial Products Market Attractiveness Analysis, by Region 12. North America Microbial Products Market Analysis 12.1. Key Findings 12.2. North America Microbial Products Market Overview 12.3. North America Microbial Products Market Value Share Analysis, By Type 12.4. North America Microbial Products Market Forecast, By Type 12.4.1. Enzymes 12.4.2. Polysaccharides 12.4.3. Nutrients 12.4.4. Chemotherapeutic Agents 12.4.5. Antibiotics 12.4.6. Vaccines 12.5. North America Microbial Products Market Value Share Analysis, By Application 12.6. North America Microbial Products Market Forecast, By Application 12.6.1. Pharmaceutical 12.6.2. Diagnostic 12.6.3. Biotechnology 12.7. North America Microbial Products Market Value Share Analysis, By Source 12.8. North America Microbial Products Market Forecast, By Source 12.8.1. Bacterial 12.8.2. Viral 12.8.3. Fungi 12.9. North America Microbial Products Market Value Share Analysis, By End-User 12.10. North America Microbial Products Market Forecast, By End-User 12.10.1. Pharmaceutical and Biotechnological Industries 12.10.2. Hospitals and Clinics 12.10.3. Diagnostic Labs 12.10.4. Research and Academics 12.11. North America Microbial Products Market Value Share Analysis, by Country 12.12. North America Microbial Products Market Forecast, by Country 12.12.1. U.S. 12.12.2. Canada 12.13. North America Microbial Products Market Analysis, by Country 12.14. U.S. Microbial Products Market Forecast, By Type 12.14.1. Enzymes 12.14.2. Polysaccharides 12.14.3. Nutrients 12.14.4. Chemotherapeutic Agents 12.14.5. Antibiotics 12.14.6. Vaccines 12.15. U.S. Microbial Products Market Forecast, By Application 12.15.1. Pharmaceutical 12.15.2. Diagnostic 12.15.3. Biotechnology 12.16. U.S. Microbial Products Market Forecast, By Source 12.16.1. Bacterial 12.16.2. Viral 12.16.3. Fungi 12.17. U.S. Microbial Products Market Forecast, By End-User 12.17.1. Pharmaceutical and Biotechnological Industries 12.17.2. Hospitals and Clinics 12.17.3. Diagnostic Labs 12.17.4. Research and Academics 12.18. Canada Microbial Products Market Forecast, By Type 12.18.1. Enzymes 12.18.2. Polysaccharides 12.18.3. Nutrients 12.18.4. Chemotherapeutic Agents 12.18.5. Antibiotics 12.18.6. Vaccines 12.19. Canada Microbial Products Market Forecast, By Application 12.19.1. Pharmaceutical 12.19.2. Diagnostic 12.19.3. Biotechnology 12.20. Canada Microbial Products Market Forecast, By Source 12.20.1. Bacterial 12.20.2. Viral 12.20.3. Fungi 12.21. Canada Microbial Products Market Forecast, By End-User 12.21.1. Pharmaceutical and Biotechnological Industries 12.21.2. Hospitals and Clinics 12.21.3. Diagnostic Labs 12.21.4. Research and Academics 12.22. North America Microbial Products Market Attractiveness Analysis 12.22.1. By Type 12.22.2. By Application 12.22.3. By Source 12.22.4. By End-User 12.23. PEST Analysis 12.24. Key Trends 12.25. Key Developments 13. Europe Microbial Products Market Analysis 13.1. Key Findings 13.2. Europe Microbial Products Market Overview 13.3. Europe Microbial Products Market Value Share Analysis, By Type 13.4. Europe Microbial Products Market Forecast, By Type 13.4.1. Enzymes 13.4.2. Polysaccharides 13.4.3. Nutrients 13.4.4. Chemotherapeutic Agents 13.4.5. Antibiotics 13.4.6. Vaccines 13.5. Europe Microbial Products Market Value Share Analysis, By Application 13.6. Europe Microbial Products Market Forecast, By Application 13.6.1. Pharmaceutical 13.6.2. Diagnostic 13.6.3. Biotechnology 13.7. Europe Microbial Products Market Value Share Analysis, By Source 13.8. Europe Microbial Products Market Forecast, By Source 13.8.1. Bacterial 13.8.2. Viral 13.8.3. Fungi 13.9. Europe Microbial Products Market Value Share Analysis, By End-User 13.10. Europe Microbial Products Market Forecast, By End-User 13.10.1. Pharmaceutical and Biotechnological Industries 13.10.2. Hospitals and Clinics 13.10.3. Diagnostic Labs 13.10.4. Research and Academics 13.11. Europe Microbial Products Market Value Share Analysis, by Country 13.12. Europe Microbial Products Market Forecast, by Country 13.12.1. Germany 13.12.2. U.K. 13.12.3. France 13.12.4. Italy 13.12.5. Spain 13.12.6. Rest of Europe 13.13. Europe Microbial Products Market Analysis, by Country 13.14. Germany Microbial Products Market Forecast, By Type 13.14.1. Enzymes 13.14.2. Polysaccharides 13.14.3. Nutrients 13.14.4. Chemotherapeutic Agents 13.14.5. Antibiotics 13.14.6. Vaccines 13.15. Germany Microbial Products Market Forecast, By Application 13.15.1. Pharmaceutical 13.15.2. Diagnostic 13.15.3. Biotechnology 13.16. Germany Microbial Products Market Forecast, By Source 13.16.1. Bacterial 13.16.2. Viral 13.16.3. Fungi 13.17. Germany Microbial Products Market Forecast, By End-User 13.17.1. Pharmaceutical and Biotechnological Industries 13.17.2. Hospitals and Clinics 13.17.3. Diagnostic Labs 13.17.4. Research and Academics 13.18. U.K. Microbial Products Market Forecast, By Type 13.18.1. Enzymes 13.18.2. Polysaccharides 13.18.3. Nutrients 13.18.4. Chemotherapeutic Agents 13.18.5. Antibiotics 13.18.6. Vaccines 13.19. U.K. Microbial Products Market Forecast, By Application 13.19.1. Pharmaceutical 13.19.2. Diagnostic 13.19.3. Biotechnology 13.20. U.K. Microbial Products Market Forecast, By Source 13.20.1. Bacterial 13.20.2. Viral 13.20.3. Fungi 13.21. U.K. Microbial Products Market Forecast, By End-User 13.21.1. Pharmaceutical and Biotechnological Industries 13.21.2. Hospitals and Clinics 13.21.3. Diagnostic Labs 13.21.4. Research and Academics 13.22. France Microbial Products Market Forecast, By Type 13.22.1. Enzymes 13.22.2. Polysaccharides 13.22.3. Nutrients 13.22.4. Chemotherapeutic Agents 13.22.5. Antibiotics 13.22.6. Vaccines 13.23. France Microbial Products Market Forecast, By Application 13.23.1. Pharmaceutical 13.23.2. Diagnostic 13.23.3. Biotechnology 13.24. France Microbial Products Market Forecast, By Source 13.24.1. Bacterial 13.24.2. Viral 13.24.3. Fungi 13.25. France Microbial Products Market Forecast, By End-User 13.25.1. Pharmaceutical and Biotechnological Industries 13.25.2. Hospitals and Clinics 13.25.3. Diagnostic Labs 13.25.4. Research and Academics 13.26. Italy Microbial Products Market Forecast, By Type 13.26.1. Enzymes 13.26.2. Polysaccharides 13.26.3. Nutrients 13.26.4. Chemotherapeutic Agents 13.26.5. Antibiotics 13.26.6. Vaccines 13.27. Italy Microbial Products Market Forecast, By Application 13.27.1. Pharmaceutical 13.27.2. Diagnostic 13.27.3. Biotechnology 13.28. Italy Microbial Products Market Forecast, By Source 13.28.1. Bacterial 13.28.2. Viral 13.28.3. Fungi 13.29. Italy Microbial Products Market Forecast, By End-User 13.29.1. Pharmaceutical and Biotechnological Industries 13.29.2. Hospitals and Clinics 13.29.3. Diagnostic Labs 13.29.4. Research and Academics 13.30. Spain Microbial Products Market Forecast, By Type 13.30.1. Enzymes 13.30.2. Polysaccharides 13.30.3. Nutrients 13.30.4. Chemotherapeutic Agents 13.30.5. Antibiotics 13.30.6. Vaccines 13.31. Spain Microbial Products Market Forecast, By Application 13.31.1. Pharmaceutical 13.31.2. Diagnostic 13.31.3. Biotechnology 13.32. Spain Microbial Products Market Forecast, By Source 13.32.1. Bacterial 13.32.2. Viral 13.32.3. Fungi 13.33. Spain Microbial Products Market Forecast, By End-User 13.33.1. Pharmaceutical and Biotechnological Industries 13.33.2. Hospitals and Clinics 13.33.3. Diagnostic Labs 13.33.4. Research and Academics 13.34. Rest of Europe Microbial Products Market Forecast, By Type 13.34.1. Enzymes 13.34.2. Polysaccharides 13.34.3. Nutrients 13.34.4. Chemotherapeutic Agents 13.34.5. Antibiotics 13.34.6. Vaccines 13.35. Rest of Europe Microbial Products Market Forecast, By Application 13.35.1. Pharmaceutical 13.35.2. Diagnostic 13.35.3. Biotechnology 13.36. Rest of Europe Microbial Products Market Forecast, By Source 13.36.1. Bacterial 13.36.2. Viral 13.36.3. Fungi 13.37. Rest Of Europe Microbial Products Market Forecast, By End-User 13.37.1. Pharmaceutical and Biotechnological Industries 13.37.2. Hospitals and Clinics 13.37.3. Diagnostic Labs 13.37.4. Research and Academics 13.38. Europe Microbial Products Market Attractiveness Analysis 13.38.1. By Type 13.38.2. By Application 13.38.3. By Source 13.38.4. By End-User 13.39. PEST Analysis 13.40. Key Trends 13.41. Key Developments 14. Asia Pacific Microbial Products Market Analysis 14.1. Key Findings 14.2. Asia Pacific Microbial Products Market Overview 14.3. Asia Pacific Microbial Products Market Value Share Analysis, By Type 14.4. Asia Pacific Microbial Products Market Forecast, By Type 14.4.1. Enzymes 14.4.2. Polysaccharides 14.4.3. Nutrients 14.4.4. Chemotherapeutic Agents 14.4.5. Antibiotics 14.4.6. Vaccines 14.5. Asia Pacific Microbial Products Market Value Share Analysis, By Application 14.6. Asia Pacific Microbial Products Market Forecast, By Application 14.6.1. Pharmaceutical 14.6.2. Diagnostic 14.6.3. Biotechnology 14.7. Asia Pacific Microbial Products Market Value Share Analysis, By Source 14.8. Asia Pacific Microbial Products Market Forecast, By Source 14.8.1. Bacterial 14.8.2. Viral 14.8.3. Fungi 14.9. Asia Pacific Microbial Products Market Value Share Analysis, By End-User 14.10. Asia Pacific Microbial Products Market Forecast, By End-User 14.10.1. Pharmaceutical and Biotechnological Industries 14.10.2. Hospitals and Clinics 14.10.3. Diagnostic Labs 14.10.4. Research and Academics 14.11. Asia Pacific Microbial Products Market Value Share Analysis, by Country 14.12. Asia Pacific Microbial Products Market Forecast, by Country 14.12.1. China 14.12.2. India 14.12.3. Japan 14.12.4. ASEAN 14.12.5. Rest of Asia Pacific 14.13. Asia Pacific Microbial Products Market Analysis, by Country 14.14. China Microbial Products Market Forecast, By Type 14.14.1. Enzymes 14.14.2. Polysaccharides 14.14.3. Nutrients 14.14.4. Chemotherapeutic Agents 14.14.5. Antibiotics 14.14.6. Vaccines 14.15. China Microbial Products Market Forecast, By Application 14.15.1. Pharmaceutical 14.15.2. Diagnostic 14.15.3. Biotechnology 14.16. China Microbial Products Market Forecast, By Source 14.16.1. Bacterial 14.16.2. Viral 14.16.3. Fungi 14.17. China Microbial Products Market Forecast, By End-User 14.17.1. Pharmaceutical and Biotechnological Industries 14.17.2. Hospitals and Clinics 14.17.3. Diagnostic Labs 14.17.4. Research and Academics 14.18. India Microbial Products Market Forecast, By Type 14.18.1. Enzymes 14.18.2. Polysaccharides 14.18.3. Nutrients 14.18.4. Chemotherapeutic Agents 14.18.5. Antibiotics 14.18.6. Vaccines 14.19. India Microbial Products Market Forecast, By Application 14.19.1. Pharmaceutical 14.19.2. Diagnostic 14.19.3. Biotechnology 14.20. India Microbial Products Market Forecast, By Source 14.20.1. Bacterial 14.20.2. Viral 14.20.3. Fungi 14.21. India Microbial Products Market Forecast, By End-User 14.21.1. Pharmaceutical and Biotechnological Industries 14.21.2. Hospitals and Clinics 14.21.3. Diagnostic Labs 14.21.4. Research and Academics 14.22. Japan Microbial Products Market Forecast, By Type 14.22.1. Enzymes 14.22.2. Polysaccharides 14.22.3. Nutrients 14.22.4. Chemotherapeutic Agents 14.22.5. Antibiotics 14.22.6. Vaccines 14.23. Japan Microbial Products Market Forecast, By Application 14.23.1. Pharmaceutical 14.23.2. Diagnostic 14.23.3. Biotechnology 14.24. Japan Microbial Products Market Forecast, By Source 14.24.1. Bacterial 14.24.2. Viral 14.24.3. Fungi 14.25. Japan Microbial Products Market Forecast, By End-User 14.25.1. Pharmaceutical and Biotechnological Industries 14.25.2. Hospitals and Clinics 14.25.3. Diagnostic Labs 14.25.4. Research and Academics 14.26. ASEAN Microbial Products Market Forecast, By Type 14.26.1. Enzymes 14.26.2. Polysaccharides 14.26.3. Nutrients 14.26.4. Chemotherapeutic Agents 14.26.5. Antibiotics 14.26.6. Vaccines 14.27. ASEAN Microbial Products Market Forecast, By Application 14.27.1. Pharmaceutical 14.27.2. Diagnostic 14.27.3. Biotechnology 14.28. ASEAN Microbial Products Market Forecast, By Source 14.28.1. Bacterial 14.28.2. Viral 14.28.3. Fungi 14.29. ASEAN Microbial Products Market Forecast, By End-User 14.29.1. Pharmaceutical and Biotechnological Industries 14.29.2. Hospitals and Clinics 14.29.3. Diagnostic Labs 14.29.4. Research and Academics 14.30. Rest of Asia Pacific Microbial Products Market Forecast, By Type 14.30.1. Enzymes 14.30.2. Polysaccharides 14.30.3. Nutrients 14.30.4. Chemotherapeutic Agents 14.30.5. Antibiotics 14.30.6. Vaccines 14.31. Rest of Asia Pacific Microbial Products Market Forecast, By Application 14.31.1. Pharmaceutical 14.31.2. Diagnostic 14.31.3. Biotechnology 14.32. Rest of Asia Pacific Microbial Products Market Forecast, By Source 14.32.1. Bacterial 14.32.2. Viral 14.32.3. Fungi 14.33. Rest of Asia Pacific Microbial Products Market Forecast, By End-User 14.33.1. Pharmaceutical and Biotechnological Industries 14.33.2. Hospitals and Clinics 14.33.3. Diagnostic Labs 14.33.4. Research and Academics 14.34. Asia Pacific Microbial Products Market Attractiveness Analysis 14.34.1. By Type 14.34.2. By Application 14.34.3. By Source 14.34.4. By End-User 14.35. PEST Analysis 14.36. Key Trends 14.37. Key Developments 15. Middle East & Africa Microbial Products Market Analysis 15.1. Key Findings 15.2. Middle East & Africa Microbial Products Market Overview 15.3. Middle East & Africa Microbial Products Market Value Share Analysis, By Type 15.4. Middle East & Africa Microbial Products Market Forecast, By Type 15.4.1. Enzymes 15.4.2. Polysaccharides 15.4.3. Nutrients 15.4.4. Chemotherapeutic Agents 15.4.5. Antibiotics 15.4.6. Vaccines 15.5. Middle East & Africa Microbial Products Market Value Share Analysis, By Application 15.6. Middle East & Africa Microbial Products Market Forecast, By Application 15.6.1. Pharmaceutical 15.6.2. Diagnostic 15.6.3. Biotechnology 15.7. Middle East & Africa Microbial Products Market Value Share Analysis, By Source 15.8. Middle East & Africa Microbial Products Market Forecast, By Source 15.8.1. Bacterial 15.8.2. Viral 15.8.3. Fungi 15.9. Middle East & Africa Microbial Products Market Value Share Analysis, By End-User 15.10. Middle East & Africa Microbial Products Market Forecast, By End-User 15.10.1. Pharmaceutical and Biotechnological Industries 15.10.2. Hospitals and Clinics 15.10.3. Diagnostic Labs 15.10.4. Research and Academics 15.11. Middle East & Africa Microbial Products Market Value Share Analysis, by Country 15.12. Middle East & Africa Microbial Products Market Forecast, by Country 15.12.1. GCC 15.12.2. South Africa 15.12.3. Rest of Middle East & Africa 15.13. Middle East & Africa Microbial Products Market Analysis, by Country 15.14. GCC Microbial Products Market Forecast, By Type 15.14.1. Enzymes 15.14.2. Polysaccharides 15.14.3. Nutrients 15.14.4. Chemotherapeutic Agents 15.14.5. Antibiotics 15.14.6. Vaccines 15.15. GCC Microbial Products Market Forecast, By Application 15.15.1. Pharmaceutical 15.15.2. Diagnostic 15.15.3. Biotechnology 15.16. GCC Microbial Products Market Forecast, By Source 15.16.1. Bacterial 15.16.2. Viral 15.16.3. Fungi 15.17. GCC Microbial Products Market Forecast, By End-User 15.17.1. Pharmaceutical and Biotechnological Industries 15.17.2. Hospitals and Clinics 15.17.3. Diagnostic Labs 15.17.4. Research and Academics 15.18. South Africa Microbial Products Market Forecast, By Type 15.18.1. Enzymes 15.18.2. Polysaccharides 15.18.3. Nutrients 15.18.4. Chemotherapeutic Agents 15.18.5. Antibiotics 15.18.6. Vaccines 15.19. South Africa Microbial Products Market Forecast, By Application 15.19.1. Pharmaceutical 15.19.2. Diagnostic 15.19.3. Biotechnology 15.20. South Africa Microbial Products Market Forecast, By Source 15.20.1. Bacterial 15.20.2. Viral 15.20.3. Fungi 15.21. South Africa Microbial Products Market Forecast, By End-User 15.21.1. Pharmaceutical and Biotechnological Industries 15.21.2. Hospitals and Clinics 15.21.3. Diagnostic Labs 15.21.4. Research and Academics 15.22. Rest of Middle East & Africa Microbial Products Market Forecast, By Type 15.22.1. Enzymes 15.22.2. Polysaccharides 15.22.3. Nutrients 15.22.4. Chemotherapeutic Agents 15.22.5. Antibiotics 15.22.6. Vaccines 15.23. Rest of Middle East & Africa Microbial Products Market Forecast, By Application 15.23.1. Pharmaceutical 15.23.2. Diagnostic 15.23.3. Biotechnology 15.24. Rest of Middle East & Africa Microbial Products Market Forecast, By Source 15.24.1. Bacterial 15.24.2. Viral 15.24.3. Fungi 15.25. Rest of Middle East & Africa Microbial Products Market Forecast, By End-User 15.25.1. Pharmaceutical and Biotechnological Industries 15.25.2. Hospitals and Clinics 15.25.3. Diagnostic Labs 15.25.4. Research and Academics 15.26. Middle East & Africa Microbial Products Market Attractiveness Analysis 15.26.1. By Type 15.26.2. By Application 15.26.3. By Source 15.26.4. By End-User 15.27. PEST Analysis 15.28. Key Trends 15.29. Key Developments 16. South America Microbial Products Market Analysis 16.1. Key Findings 16.2. South America Microbial Products Market Overview 16.3. South America Microbial Products Market Value Share Analysis, By Type 16.4. South America Microbial Products Market Forecast, By Type 16.4.1. Enzymes 16.4.2. Polysaccharides 16.4.3. Nutrients 16.4.4. Chemotherapeutic Agents 16.4.5. Antibiotics 16.4.6. Vaccines 16.5. South America Microbial Products Market Value Share Analysis, By Application 16.6. South America Microbial Products Market Forecast, By Application 16.6.1. Pharmaceutical 16.6.2. Diagnostic 16.6.3. Biotechnology 16.7. South America Microbial Products Market Value Share Analysis, By Source 16.8. South America Microbial Products Market Forecast, By Source 16.8.1. Bacterial 16.8.2. Viral 16.8.3. Fungi 16.9. South America Microbial Products Market Value Share Analysis, By End-User 16.10. South America Microbial Products Market Forecast, By End-User 16.10.1. Pharmaceutical and Biotechnological Industries 16.10.2. Hospitals and Clinics 16.10.3. Diagnostic Labs 16.10.4. Research and Academics 16.11. South America Microbial Products Market Value Share Analysis, by Country 16.12. South America Microbial Products Market Forecast, by Country 16.12.1. Brazil 16.12.2. Mexico 16.12.3. Rest of South America 16.13. South America Microbial Products Market Analysis, by Country 16.14. Brazil Microbial Products Market Forecast, By Type 16.14.1. Enzymes 16.14.2. Polysaccharides 16.14.3. Nutrients 16.14.4. Chemotherapeutic Agents 16.14.5. Antibiotics 16.14.6. Vaccines 16.15. Brazil Microbial Products Market Forecast, By Application 16.15.1. Pharmaceutical 16.15.2. Diagnostic 16.15.3. Biotechnology 16.16. Brazil Microbial Products Market Forecast, By Source 16.16.1. Bacterial 16.16.2. Viral 16.16.3. Fungi 16.17. Brazil Microbial Products Market Forecast, By End-User 16.17.1. Pharmaceutical and Biotechnological Industries 16.17.2. Hospitals and Clinics 16.17.3. Diagnostic Labs 16.17.4. Research and Academics 16.18. Mexico Microbial Products Market Forecast, By Type 16.18.1. Enzymes 16.18.2. Polysaccharides 16.18.3. Nutrients 16.18.4. Chemotherapeutic Agents 16.18.5. Antibiotics 16.18.6. Vaccines 16.19. Mexico Microbial Products Market Forecast, By Application 16.19.1. Pharmaceutical 16.19.2. Diagnostic 16.19.3. Biotechnology 16.20. Mexico Microbial Products Market Forecast, By Source 16.20.1. Bacterial 16.20.2. Viral 16.20.3. Fungi 16.21. Mexico Microbial Products Market Forecast, By End-User 16.21.1. Pharmaceutical and Biotechnological Industries 16.21.2. Hospitals and Clinics 16.21.3. Diagnostic Labs 16.21.4. Research and Academics 16.22. Rest of South America Microbial Products Market Forecast, By Type 16.22.1. Enzymes 16.22.2. Polysaccharides 16.22.3. Nutrients 16.22.4. Chemotherapeutic Agents 16.22.5. Antibiotics 16.22.6. Vaccines 16.23. Rest of South America Microbial Products Market Forecast, By Application 16.23.1. Pharmaceutical 16.23.2. Diagnostic 16.23.3. Biotechnology 16.24. Rest of South America Microbial Products Market Forecast, By Source 16.24.1. Bacterial 16.24.2. Viral 16.24.3. Fungi 16.25. Rest of South America Microbial Products Market Forecast, By End-User 16.25.1. Pharmaceutical and Biotechnological Industries 16.25.2. Hospitals and Clinics 16.25.3. Diagnostic Labs 16.25.4. Research and Academics 16.26. South America Microbial Products Market Attractiveness Analysis 16.26.1. By Type 16.26.2. By Application 16.26.3. By Source 16.26.4. By End-User 16.27. PEST Analysis 16.28. Key Trends 16.29. Key Developments 17. Company Profiles 17.1. Market Share Analysis, by Company 17.2. Competition Matrix 17.2.1. Competitive Benchmarking of key players by price, presence, market share, Applications and R&D investment 17.2.2. New Product Launches and Product Enhancements 17.2.3. Market Consolidation 17.2.3.1. M&A by Regions, Investment and Applications 17.2.3.2. M&A Key Players, Forward Integration and Backward 17.2.3.3. Integration 17.3. Company Profiles: Key Players 17.3.1. Kyowa Hakko Bio Co 17.3.1.1. Company Overview 17.3.1.2. Financial Overview 17.3.1.3. Product Portfolio 17.3.1.4. Business Strategy 17.3.1.5. Recent Developments 17.3.1.6. Development Footprint 17.3.2. GlaxoSmithKline plc, 17.3.3. NovaDigm Therapeutics 17.3.4. Sanofi S.A 17.3.5. Novartis AG 17.3.6. Merck & Co. Inc. 17.3.7. Valent BioSciences Corp. 17.3.8. Amgen Inc. 17.3.9. Pfizer Inc., Ltd 17.3.10. Biomérieux SA 17.3.11. Ajinomoto Co. Inc. 17.3.12. Certis Usa 17.3.13. Durect Corp. 17.3.14. Earthrise Nutritionals Llc 17.3.15. Energy Derived 17.3.16. Environmental Biotechnologies Inc. 17.3.17. Genomatica 17.3.18. Genzyme Corp 17.3.19. Taiwan Chlorella Manufacturing Co. 17.3.20. Leadiant 17.3.21. AB Mauri 17.3.22. Genencor 17.3.23. Amyris Inc. 18. Primary Key Insights